Jefferies Group LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $10.7 Million - $17.2 Million	-349,000 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$31.4 - $69.84 $9.09 Million - $20.2 Million	289,400 Added 485.57%	349,000 $11.5 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $9.09 Million - $20.2 Million	289,400 Added 485.57%	349,000 $11.5 Million
Q2 2021 Sep 21, 2023	BUY	$40.9 - $64.9 $2.44 Million - $3.87 Million	59,600 New	59,600 $3.77 Million
Q2 2021 Aug 20, 2021	SELL	$40.9 - $64.9 $241 Million - $383 Million	-5,900,400 Reduced 99.0%	59,600 $3.77 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $244 Million - $387 Million	5,960,000 New	5,960,000 $3.77 Million

310

113M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.